Physician profile
Richelle Sheets
NPI 1821640699
$1,550.38
in general payments reported to CMS, 2019-2025
18 companies · $524 in 2025
The $524 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $464 · 2022: $223 · 2024: $338 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $758 · Education: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $758.31 |
| Education | $104.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $288.31 | 2021-2024 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Axsome Therapeutics, INC. | $170.59 | 2024-2025 | Auvelity |
| Abbvie INC. | $157.72 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $134.56 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $123.37 | 2025 | Austedo Xr |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $116.23 | 2021-2025 | Caplyta |
| Indivior INC. | $102.93 | 2024-2025 | Sublocade |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $88.73 | 2022 | |
| Lundbeck LLC | $68.92 | 2021-2024 | Rexulti |
| Neurocrine Biosciences, INC. | $62.02 | 2025 | |
| Sunovion Pharmaceuticals INC. | $49.43 | 2021 | |
| Braeburn INC. | $48.59 | 2024-2025 | Brixadi |
| Vanda Pharmaceuticals INC. | $38.46 | 2025 | Fanapt |
| Eisai INC. | $34.55 | 2021 | |
| Alkermes, INC. | $18.36 | 2025 | Aristada, Lybalvi |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $16.48 | 2021 | |
| Jazz Pharmaceuticals INC. | $15.67 | 2021 | |
| Bausch Health US, LLC | $15.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richelle Sheets listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.